Explore the revolutionary approach of targeting patient-specific mutation-derived tumor antigens for cancer immunotherapy in Multiple Myeloma.
Discover how the CS1 protein is revolutionizing multiple myeloma treatment through targeted immunotherapy approaches like elotuzumab.
Discover how CD26 inhibition enhances stem cell migration in G-CSF + plerixafor mobilized peripheral blood for multiple myeloma autografts.